alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.2


 





AMENDMENT TO EMPLOYMENT AGREEMENT


 


This Amendment (this “Amendment”)
effective as of the 11th day of March, 2019 to the Employment Agreement, initially effective as of July 31, 2018 (the “Employment
Agreement”), by and between Adial Pharmaceuticals, Inc. (the “Corporation”) and Joseph Truluck (“Executive”).
Capitalized terms used herein without definition shall have the meanings assigned in the Employment Agreement.  


 


WHEREAS, Executive
was retained under the Employment Agreement by the Corporation to serve as its Chief Financial Officer; and


 


WHEREAS, in recognition
of the hard work and performance by Executive, the Corporation desires to amend the Employment Agreement.


 


NOW THEREFORE, for
the mutual promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree to amend the Employment Agreement as follows:


 


1. Amendment.
Section 3.1 of the Employment Agreement is hereby deleted in its entirety and replaced with the following:


“3.1Base
Salary. During the Term of Employment, the Executive shall initially receive a base salary per annum of One Hundred Fifty
Thousand Dollars ($150,000), payable in cash in accordance with the Company’s normal payroll practices as in effect from
time to time. During the Term of Employment, the Board may periodically review the Executive’s base salary and the Board
(excluding the Executive) may, in its sole discretion, set such base salary to an amount it determines to be appropriate, provided,
however, that any reduction will qualify as Good Reason under Section 1.11. The Executive’s base salary, as may be in effect
from time to time, is referred to herein as “Base Salary.””


2. Severability.
The provisions of this Amendment are severable and if any part of it is found to be unenforceable the other paragraphs shall remain
fully valid and enforceable.


 


3. No Other Amendments;
Confirmation. All other terms of the Employment Agreement shall remain in full force and effect. The Employment Agreement,
as amended by this Amendment, constitutes the entire agreement between the parties with respect to the subject matter thereof.


 


4. Counterparts.
 This Amendment may be executed in one or more counterparts, each of which shall be deemed an original but both of which together
shall constitute one and the same instrument.


 


5. Governing Law.
This Amendment is made and shall be construed and performed under the laws of the Commonwealth of Virginia without regard to its
choice or conflict of law principles and the parties agree to Virginia as the exclusive venue for any disputes arising hereunder.


 


 


[Signature page follows]









    	 		 



     


    

 





IN WITNESS WHEREOF, the parties hereto
have caused this Amendment to the Employment Agreement to be duly executed as of the day and year first above written.


 


	 	 	 
	 	 	 
	 	ADIAL PHARMACEUTICALS, INC.
	 	 	 
	 	By: 	/s/ William B. Stilley
	 	Name: 	William B. Stilley, III
	 	Title: 	Chief Executive Officer
	 	 	 
	 	
        

         

        /s/ Joseph Truluck

	 	JOSEPH TRULUCK
Jason Brian BRAUN, petitioner, v. DEPARTMENT OF THE INTERIOR, et al.

No. 18-1263.

Supreme Court of the United States

May 28, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.
# National Day of Prayer, 2022

Throughout our history, prayer has been an anchor for countless Americans searching for strength and wisdom in times of struggle and sharing hope and gratitude in seasons of joy. In public reflections on life's many blessings and in quiet moments during life's most difficult trials, Americans of nearly every background and faith have turned to prayer for comfort and inspiration. Prayer is a sacred right protected by free speech and religious liberty enshrined in our Constitution, and it continues to lift our spirits as we navigate the challenges of our time.

On this day, we recognize the healing power of prayer, especially as we recover from the trauma and loss of the COVID-19 pandemic. Today we find ourselves in a moment of renewal—of lives saved, of new jobs created, and of new hope for rebuilding America. Today is also a moment of reflection when we are called to address some of the greatest challenges humanity has ever faced—saving our planet from the existential threat of climate change; responding to attacks on democracy at home and abroad; and living up to our Nation's promise of liberty, justice, and equality for all.

As the late President Dwight D. Eisenhower once said, “There is a need we all have in these days and times for some help which comes from outside ourselves.” Across our diverse and cherished beliefs, on this National Day of Prayer, no matter how or whether we pray, we are all called to look outside ourselves. Let us find in our hearts and prayers the determination to put aside our differences, come together, and truly see one another as fellow Americans.

The Congress, by Public Law 100-307, as amended, has called on the President to issue each year a proclamation designating the first Thursday in May as a “National Day of Prayer.”

NOW, THEREFORE, I, JOSEPH R. BIDEN JR., President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim May 5, 2022, as a National Day of Prayer. I call upon the citizens of our Nation to give thanks, in accordance with their own faiths and consciences, for our many freedoms and blessings, and I invite all people of faith to join me in asking for God's continued guidance, mercy, and protection.

IN WITNESS WHEREOF, I have hereunto set my hand this fourth day of May, in the year of our Lord two thousand twenty-two, and of the Independence of the United States of America the two hundred and forty-sixth.

[FR Doc. 2022-10075

Billing code 3395-F2-P
Exhibit 32.2





CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the quarterly report on Form 10-Q of Bedford Property Investors, Inc. (the Company) for the quarter ended September 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Hanh Kihara, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 906), that:



1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date:November 11, 2003

/s/ Hanh Kihara



Hanh Kihara

Chief Financial Officer







A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
null

767.1528
# Jornal Oficial C 41/2022

| | ISSN 1977-1010 |
| --- | --- |
| Jornal Oficial
  da União Europeia | C 41 |
| | |
| Edição em língua portuguesa | Comunicações e Informações | 65.° ano27 de janeiro de 2022 |

ISSN 1977-1010

Jornal Oficial

da União Europeia

C 41

Edição em língua portuguesa

Comunicações e Informações

65.° ano27 de janeiro de 2022

---

| Índice | Página |
| --- | --- |
| | IV   Informações |
| | INFORMAÇÕES DAS INSTITUIÇÕES, ÓRGÃOS E ORGANISMOS DA UNIÃO EUROPEIA |
| | Comissão Europeia |
| 2022/C 41/01 | Taxas de câmbio do euro — 26 de janeiro de 2022 | 1 |

Índice

Página

IV   Informações

INFORMAÇÕES DAS INSTITUIÇÕES, ÓRGÃOS E ORGANISMOS DA UNIÃO EUROPEIA

Comissão Europeia

2022/C 41/01

Taxas de câmbio do euro — 26 de janeiro de 2022

1

---

| PT | |
| --- | --- |

PT

---

IV Informações

INFORMAÇÕES DAS INSTITUIÇÕES, ÓRGÃOS E ORGANISMOS DA UNIÃO EUROPEIA

Comissão Europeia

| 27.1.2022 | PT | Jornal Oficial da União Europeia | C 41/1 |
| --- | --- | --- | --- |

27.1.2022

PT

Jornal Oficial da União Europeia

C 41/1

---

Taxas de câmbio do euro (1)

26 de janeiro de 2022

(2022/C 41/01)

1 euro =

| | Moeda | Taxas de câmbio |
| --- | --- | --- |
| USD | dólar dos Estados Unidos | 1,1277 |
| JPY | iene | 128,86 |
| DKK | coroa dinamarquesa | 7,4420 |
| GBP | libra esterlina | 0,83458 |
| SEK | coroa sueca | 10,4493 |
| CHF | franco suíço | 1,0386 |
| ISK | coroa islandesa | 145,60 |
| NOK | coroa norueguesa | 10,0115 |
| BGN | lev | 1,9558 |
| CZK | coroa checa | 24,531 |
| HUF | forint | 359,67 |
| PLN | zlóti | 4,5864 |
| RON | leu romeno | 4,9451 |
| TRY | lira turca | 15,2877 |
| AUD | dólar australiano | 1,5727 |
| CAD | dólar canadiano | 1,4173 |
| HKD | dólar de Hong Kong | 8,7791 |
| NZD | dólar neozelandês | 1,6865 |
| SGD | dólar singapurense | 1,5162 |
| KRW | won sul-coreano | 1 350,03 |
| ZAR | rand | 17,0858 |
| CNY | iuane | 7,1293 |
| HRK | kuna | 7,5290 |
| IDR | rupia indonésia | 16 185,31 |
| MYR | ringgit | 4,7268 |
| PHP | peso filipino | 57,728 |
| RUB | rublo | 89,2650 |
| THB | baht | 37,169 |
| BRL | real | 6,1084 |
| MXN | peso mexicano | 23,1845 |
| INR | rupia indiana | 84,4288 |

Moeda

Taxas de câmbio

USD

dólar dos Estados Unidos

1,1277

JPY

iene

128,86

DKK

coroa dinamarquesa

7,4420

GBP

libra esterlina

0,83458

SEK

coroa sueca

10,4493

CHF

franco suíço

1,0386

ISK

coroa islandesa

145,60

NOK

coroa norueguesa

10,0115

BGN

lev

1,9558

CZK

coroa checa

24,531

HUF

forint

359,67

PLN

zlóti

4,5864

RON

leu romeno

4,9451

TRY

lira turca

15,2877

AUD

dólar australiano

1,5727

CAD

dólar canadiano

1,4173

HKD

dólar de Hong Kong

8,7791

NZD

dólar neozelandês

1,6865

SGD

dólar singapurense

1,5162

KRW

won sul-coreano

1 350,03

ZAR

rand

17,0858

CNY

iuane

7,1293

HRK

kuna

7,5290

IDR

rupia indonésia

16 185,31

MYR

ringgit

4,7268

PHP

peso filipino

57,728

RUB

rublo

89,2650

THB

baht

37,169

BRL

real

6,1084

MXN

peso mexicano

23,1845

INR

rupia indiana

84,4288

---

(1)  Fonte: Taxas de câmbio de referência publicadas pelo Banco Central Europeu.

---
Anthony J. DANNOLFO, petitioner, v. Mark S. INCH, Secretary, Florida Department of Corrections.

No. 18-8003.

Supreme Court of the United States

June 10, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Charles G. KINNEY, petitioner, v. Michele Renee CLARK.

No. 18-1351.

Supreme Court of the United States

June 3, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
```
 
 
MSCI EAFE MINI INDEX - NYSE LIFFE                                    Code-244041
OPTION AND FUTURES COMBINED POSITIONS AS OF 09/13/11          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
(MSCI EAFE INDEX X $50)                              OPEN INTEREST:       47,440
COMMITMENTS
   2,450      430      308   40,405   44,575   43,163   45,313    4,277    2,127

CHANGES FROM 09/06/11 (CHANGE IN OPEN INTEREST:      5,489)
    -900      -60      308    5,387    4,238    4,795    4,486      694    1,003

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
     5.2      0.9      0.6     85.2     94.0     91.0     95.5      9.0      4.5

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:       53)
       6        2        3       31       30       38       34
 
 
MSCI EMERGING MKTS MINI INDEX - NYSE LIFFE                           Code-244042
OPTION AND FUTURES COMBINED POSITIONS AS OF 09/13/11          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
(MSCI EAFE INDEX X $50)                              OPEN INTEREST:       65,111
COMMITMENTS
   4,572    6,447      449   47,697   49,707   52,718   56,603   12,393    8,508

CHANGES FROM 09/06/11 (CHANGE IN OPEN INTEREST:      9,869)
    -758       20      448    5,056    6,471    4,746    6,939    5,123    2,930

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
     7.0      9.9      0.7     73.3     76.3     81.0     86.9     19.0     13.1

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:       72)
      14        3        3       42       31       56       37
```

----

Updated September 16, 2011
ex_137069.htm


Exhibit 10.3


 


AMENDMENT


TO THE PROMISSORY NOTE AND WARRANT DATED SEPTEMBER 19, 2018


 


The parties entered into a 12% Promissory Note dated September 19, 2018 in the Original Principal Amount of $280,000, instrument number 33146, (the “Note”), by and between BioLargo, Inc. (the “Issuer”) and Vernal Bay Investments, LLC (the “Holder”) (together referred to as the “Parties”). All capitalized terms not otherwise defined herein have the meaning set forth in the Note.


 


WHEREAS, the Note’s original Maturity Date was January 5, 2019, and pursuant to the terms thereof, on January 3, 2019, Issuer notified Holder of its election to extend the Maturity Date by 60 days to March 6, 2019, and in doing so the Principal Amount due under the Note increased as of January 3, 2019 to $308,000.


 


WHEREAS, the Parties have agreed to further extend the Maturity Date of the Note as set forth herein.


 


The Parties hereby agree to amend the Note as follows:


 


Maturity: The Maturity Date of the Note shall be extended to June 6, 2019.


 


Optional Extension of June 6, 2019 Maturity Date. So long as an Event of Default (as defined in Section 4 of the Note) has not occurred, Issuer may extend the Maturity Date of the Note to September 6, 2019 by giving written notice to Holder at any time prior to the Maturity Date, and in such event the then outstanding Principal Amount of the Note will increase by ten percent (10%), effective as of the date of the notice.


 


Interest Rate: Effective as of March 7, 2019, the Note shall earn interest at the rate of eighteen percent (18%) per annum. For the purpose of clarity, all interest accrued prior to March 7, 2019 accrued at 12% per annum.


 


Amendment to Warrant: Issuer issued to Holder a warrant to purchase 1,387,500 shares of Issuer’s common stock, instrument number 33147, expiring September 19, 2023 (the “Warrant”). As additional consideration for the extension, the Exercise Price of the Warrant (as that term is defined in the Warrant) is hereby reduced from $0.25 to $0.20, and the number of share purchasable under the Warrant is hereby increased from 1,387,500 to 1,734,375 shares.


 


ALL OTHER TERMS AND CONDITIONS OF THE NOTE AND WARRANT REMAIN IN FULL FORCE AND EFFECT.


 


Please indicate acceptance and approval of this amendment dated March 5, 2019 by signing below:


 


	/s/Dennis P. Calvert	 	/s/Robert E. Boyer	 
	Dennis P. Calvert 	 	Robert E. Boyer	 
	BioLargo, Inc.	 	Vernal Bay Investments, LLC	 
	Chief Executive Officer 	 	Member	 
	Date signed: March 5, 2019	 	Date signed: March 6, 2019
Joseph Michael KURZ, petitioner, v. LOUISIANA.

No. 18-8087.

Supreme Court of the United States

April 29, 2019.

Petition for writ of certiorari to the Court of Appeal of Louisiana, Second Circuit denied.
Exhibit 32.1



CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER



PURSUANT TO



18 U.S.C. SECTION 1350,



AS ADOPTED PURSUANT TO



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



I, Zvi Alon, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report on Form 10-Q of NetManage, the Periodic Report, for the period ended March 31, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 and that the information contained in such Periodic Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Periodic Report and results of
operations of the Company for the period covered by the Periodic Report.



By:

/s/ Zvi AlonName:

Zvi AlonTitle:

Chief Executive Officer




I, Michael
Peckham, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report on Form 10-Q of NetManage, the Periodic Report, for the period ended March 31,
2004 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such Periodic Report fairly presents, in all material respects, the financial condition of the Company
at the end of the period covered by the Periodic Report and results of operations of the Company for the period covered by the Periodic Report.



By:

/s/ Michael PeckhamName:

Michael PeckhamTitle:

Chief Financial Officer
Jorge Avila TORREZ, petitioner, v. UNITED STATES.

No. 17-1189.

Supreme Court of the United States

June 17, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection  with the Annual report of Airtrax,  Inc. (the  "Company") on
Form 10-KSB for the period ending December 31, 2006 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"),  I, Robert M. Watson,
Principal  Executive  Officer of the  Company,  certify,  pursuant  to 18 U.S.C.
section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities and Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.

     A signed  original of this  written  statement  required by Section 906 has
been  provided to Airtrax,  Inc.  and will be  retained  by  Airtrax,  Inc.  and
furnished to the Securities and Exchange Commission or its staff upon request.

Date:  April 16, 2007           By: /s/ ROBERT M. WATSON
                                ------------------------
                                Robert M. Watson
                                Principal Executive Officer
EX-23.1
Consent of Independent Accountants

                  CONSENT OF INDEPENDENT CHARTERED ACCOUNTANTS





We consent to the use in this Annual Report (Form 10-KSB) of Healthnet
International Inc. of our report dated April 24, 2000 with respect to the
Company's consolidated financial statements for the year ended February 29,
2000.

We consent to the incorporation by reference in the Registration Statements
(Form S-8 No. 333-92285) pertaining to the 1999 Non-Qualified Stock Option Plan
of Healthnet International Inc. of our report dated April 24, 2000 with respect
to the consolidated financial statements of Healthnet International Inc.
included in this Annual Report for the year ended February 29, 2000.



                                                           /s/ Ernst & Young LLP
Vancouver, Canada
June 12, 2000                                              Chartered Accountants
Exhibit 21



EQUISTAR CHEMICALS, LP

SUBSIDIARIES



|                                     |  |                     |  |             
|------------------------------------ |  | ------------------- |  | ------------
|Name                                 |  | Type of Entity      |  | Jurisdiction
|Equistar Mont Belvieu Corporation    |  | corporation         |  | Delaware    
|Equistar Polyproylene, LLC           |  | limited liability   |  | Delaware    
|Equistar Funding Corporation         |  | corporation         |  | Delaware    
|Equistar Chemicals de Mexico, Inc.   |  | corporation         |  | Delaware    
|PD Glycol                            |  | corporation         |  | Texas       
|Equistar Transportation Company, LLC |  | limited liability   |  | Delaware    
|Quantum Pipeline Company             |  | corporation         |  | Illinois    
|Equistar Bayport, LLC                |  | limited liability   |  | Delaware    
|Equistar Receivables, LLC            |  | limited liability   |  | Delaware    
|Equistar Receivables II, LLC         |  | limited liability   |  | Delaware    
|Equistar Olefins Offtake, LP         |  | limited partnership |  | Delaware    
|Equistar Olefins Offtake G.P., LLC   |  | limited liability   |  | Delaware    
|Equistar Olefins G.P., LLC           |  | limited liability   |  | Delaware    
|Olefins JV, LP                       |  | limited partnership |  | Delaware    
|Lyondell-Equistar Holdings Partners  |  | joint venture       |  | Delaware
Exhibit 32

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                                   AS ADDED BY
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of MIAD Systems Ltd. (the
"Company") on Form 10-KSB for the period ended September 30, 2003 as filed with
the Securities and Exchange Commission (the "Report"), I, Michael A. S. Green of
the Company, certify, pursuant to 18 U.S.C.ss. 1350, as added by ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

1.       The Report fully complies with the requirements of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

2.       To my knowledge, the information contained in the Report fairly
         presents, in all material respects, the financial condition and results
         of operations of the Company as of and for the period covered by the
         Report.






Date:  December 30, 2003                       By:  /s/ Michael A. S. Green
       -----------------                            -----------------------
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of First Asia Holdings Limited (the "Company") on Form 10-K for the year ended September 30, 2015  (the Report), I, Ms Luk Lai Ching Kimmy, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and 2) The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations. Date:  January 28, 2016      Ms Luk Lai Ching Kimmy
Chief Executive Officer
XIU JAIN SUN, petitioner, v. Philip O. OHENE, et al.

No. 18-1231.

Supreme Court of the United States

May 28, 2019.

Petition for writ of certiorari to the Appellate Division, Supreme Court of New York, Second Judicial Department denied.